Thus, increased serum PINP levels accompanied by significantly reduced CTX-I levels under anti-TNF-α treatment indicate a shift of bone turnover toward bone formation, which potentially represents an important mechanism for preventing future bone damage and disability in RA patients. This evidence concerns the gene TNF and rheumatoid arthritis.